| Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer S Misale, R Yaeger, S Hobor, E Scala, M Janakiraman, D Liska, E Valtorta, ... Nature 486 (7404), 532-536, 2012 | 2012 | 2012 |
| Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti–epidermal growth factor receptor antibody therapies S Benvenuti, A Sartore-Bianchi, F Di Nicolantonio, C Zanon, M Moroni, ... Cancer research 67 (6), 2643-2648, 2007 | 1073 | 2007 |
| Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ... Cancer discovery 3 (6), 658-673, 2013 | 695 | 2013 |
| Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility J Gudmundsson, P Sulem, DF Gudbjartsson, T Blondal, A Gylfason, ... Nature genetics 41 (10), 1122-1126, 2009 | 434 | 2009 |
| A rare variant in MYH6 is associated with high risk of sick sinus syndrome H Holm, DF Gudbjartsson, P Sulem, G Masson, HT Helgadottir, C Zanon, ... Nature genetics 43 (4), 316-320, 2011 | 355 | 2011 |
| Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers CAL Ruivenkamp, T van Wezel, C Zanon, APM Stassen, C Vlcek, ... Nature genetics 31 (3), 295-300, 2002 | 304 | 2002 |
| The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone RJ Molenaar, D Verbaan, S Lamba, C Zanon, JWM Jeuken, ... Neuro-oncology 16 (9), 1263-1273, 2014 | 242 | 2014 |
| AKT1E17K in human solid tumours FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, ... Oncogene 27 (42), 5648-5650, 2008 | 237 | 2008 |
| A sequence variant at 4p16. 3 confers susceptibility to urinary bladder cancer LA Kiemeney, P Sulem, S Besenbacher, SH Vermeulen, A Sigurdsson, ... Nature genetics 42 (5), 415-419, 2010 | 225 | 2010 |
| Isolation and characterization of microsatellite loci in a passerine bird: the reed bunting Emberiza schoeniclus O Hanotte, C Zanon, A Pugh, C Greig, A Dixon, T Burke Molecular Ecology 3 (5), 529-530, 1994 | 206 | 1994 |
| Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma A Balakrishnan, FE Bleeker, S Lamba, M Rodolfo, M Daniotti, A Scarpa, ... Cancer research 67 (8), 3545-3550, 2007 | 196 | 2007 |
| Identification of low-frequency variants associated with gout and serum uric acid levels P Sulem, DF Gudbjartsson, GB Walters, HT Helgadottir, A Helgason, ... Nature genetics 43 (11), 1127-1130, 2011 | 179 | 2011 |
| European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene T Rafnar, SH Vermeulen, P Sulem, G Thorleifsson, KK Aben, JA Witjes, ... Human molecular genetics 20 (21), 4268-4281, 2011 | 163 | 2011 |
| PIK3CA cancer mutations display gender and tissue specificity patterns S Benvenuti, M Frattini, S Arena, C Zanon, V Cappelletti, D Coradini, ... Human mutation 29 (2), 284-288, 2008 | 106 | 2008 |
| Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus SN Stacey, P Sulem, C Zanon, SA Gudjonsson, G Thorleifsson, ... PLoS genetics 6 (7), e1001029, 2010 | 100 | 2010 |
| Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression VA Lasorsa, D Formicola, P Pignataro, F Cimmino, FM Calabrese, J Mora, ... Oncotarget 7 (16), 21840, 2016 | 97 | 2016 |
| Mutational profiling of kinases in glioblastoma FE Bleeker, S Lamba, C Zanon, RJ Molenaar, TJM Hulsebos, D Troost, ... BMC cancer 14, 1-12, 2014 | 79 | 2014 |
| An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer M Agostini, KP Janssen, E D'Angelo, S Pizzini, A Zangrando, C Zanon, ... Oncotarget 6 (32), 32561, 2015 | 77 | 2015 |
| Molecular profiling of the “plexinome” in melanoma and pancreatic cancer A Balakrishnan, JY Penachioni, S Lamba, FE Bleeker, C Zanon, ... Human mutation 30 (8), 1167-1174, 2009 | 72 | 2009 |
| Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma E D'Angelo, M Fassan, I Maretto, S Pucciarelli, C Zanon, M Digito, ... Oncotarget 7 (19), 28647, 2016 | 69 | 2016 |
Sieger Leenstrahoogleraar neurochirurgie RotterdamVerified email at erasmusmc.nl
